These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3670536)

  • 61. Quantification of the effect of Lipo-PGE1 on angiogenesis.
    Eo S; Kwon C; Lee H; Cho S; Kim J; Baek G; Yeo J; Lim C
    J Plast Reconstr Aesthet Surg; 2015 Jan; 68(1):104-12. PubMed ID: 25448364
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aneurysmal dilatation of ductus arteriosus during lipo-prostaglandin E1 therapy for diaphragmatic hernia.
    Tohyama M; Baba A; Tsuno T; Aonuma K; Komiyama A
    Eur J Pediatr; 1993 Nov; 152(11):877-9. PubMed ID: 8276014
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of lipo prostaglandin E1 on distribution of cis-diamminedichloroplatinum in lung metastasis derived from Dunn osteosarcoma cell-inoculated mouse foot-pad.
    Watanabe T; Koshino T; Saito T; Takagi T; Machida J
    Cancer Lett; 1999 Jun; 140(1-2):153-60. PubMed ID: 10403554
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of prostaglandin E 1 on cerebral circulatory disturbances following subarachnoid haemorrage in man.
    Steiner L; Forster DM; Bergvall U; Carlson LA
    Neuroradiology; 1972 Jun; 4(1):20-4. PubMed ID: 5081231
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ocular and optic nerve ischemia: recognition and treatment with intravenous prostaglandin E1.
    Steigerwalt RD; Cesarone MR; Pascarella A; De Angelis M; Nebbioso M; Belcaro G; Feragalli B
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):119-24. PubMed ID: 22108487
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Alteration of therapeutic efficacy of lipid microspheres incorporating prostaglandin E1 by mixing with aqueous solution.
    Komori Y; Aiba T; Kushima M; Kawasaki H; Kurosaki Y
    J Pharm Sci; 2007 Apr; 96(4):935-43. PubMed ID: 17238198
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distribution of lipid microspheres incorporating prostaglandin E1 to vascular lesions.
    Mizushima Y; Hamano T; Haramoto S; Kiyokawa S; Yanagawa A; Nakura K; Shintome M; Watanabe M
    Prostaglandins Leukot Essent Fatty Acids; 1990 Dec; 41(4):269-72. PubMed ID: 2077541
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy of administrative intervention for neurosurgical patients with off-label use of alprostadil lipid microsphere.
    Luo Y; Fan Q; Yu Y; Zhang L; Dong L; Luo H
    Sci Rep; 2022 Sep; 12(1):15363. PubMed ID: 36100635
    [TBL] [Abstract][Full Text] [Related]  

  • 69. New aspect of anti-inflammatory action of lipo-prostaglandinE1 in the management of collagen diseases-related skin ulcer.
    Murota H; Kotobuki Y; Umegaki N; Tani M; Katayama I
    Rheumatol Int; 2008 Sep; 28(11):1127-35. PubMed ID: 18461292
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Visual improvement in a patient with paracentral acute middle maculopathy treated with prostaglandin E1.
    Steigerwalt RDJ; Nebbioso M
    Drug Discov Ther; 2020; 14(2):98-99. PubMed ID: 32378652
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lipid microspheres as novel drug carriers.
    Mizushima Y
    Drugs Exp Clin Res; 1985; 11(9):595-600. PubMed ID: 3880046
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic effect of liposomal prostaglandin E
    Li J; Wang B; Wang Y; Wu F; Li P; Li Y; Zhao L; Cui W; Ding Y; An Q; Si J
    Exp Ther Med; 2013 Jun; 5(6):1760-1764. PubMed ID: 23837069
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Therapeutic effect of epidurally administered lipo-prostaglandin e1 agonist in a rat spinal stenosis model.
    Park SH; Lee PB; Choe GY; Moon JY; Nahm FS; Kim YC
    Korean J Pain; 2014 Jul; 27(3):219-28. PubMed ID: 25031807
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatic stellate cell contraction is inhibited by lipo-prostaglandin E
    Wang XE; Watanabe S; Oide H; Hirose M; Itatsu T; Osada T; Takazakura Y; Yokoi Y; Sato N
    J Gastroenterol Hepatol; 1998 Sep; 13(S1):S14-S18. PubMed ID: 28976684
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Development of new drugs for intractable vasculitis--lipo-PGE1 and monoclonal antibody].
    Matsuda T; Hoshi K; Igarashi R; Ichikawa Y
    Nihon Rinsho; 1994 Aug; 52(8):2187-91. PubMed ID: 7933610
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pathophysiology of vasospasm.
    Weir B
    Int Anesthesiol Clin; 1982; 20(2):39-43. PubMed ID: 7085108
    [No Abstract]   [Full Text] [Related]  

  • 77. Effect of prostaglandin E1 on deposition of autologous labelled platelets onto human atherosclerotic lesions in vivo.
    Sinzinger H; O'Grady J; Fitscha P
    Postgrad Med J; 1987 Apr; 63(738):245-7. PubMed ID: 3684830
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Clinical effects of lipo-prostaglandin E1 in patients with delayed cerebral vasospasm].
    Korosue K; Izawa I; Hamano S; Ishida K; Kurihara E; Nagao T; Tamaki N; Matsumoto S
    No Shinkei Geka; 1987 Jun; 15(6):635-40. PubMed ID: 3670536
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Lipo prostaglandin E1 administration in the acute stage following subarachnoid hemorrhage].
    Korosue K; Kondoh T; Ishikawa A; Suzuki H; Nagao T; Tamaki N; Matsumoto S
    No Shinkei Geka; 1988; 16(5 Suppl):509-15. PubMed ID: 3399005
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical and hemodynamic effects of lipo PGE1 in cerebral infarction].
    Korosue K; Kondoh T; Ishikawa A; Suzuki H; Nagao T; Tamaki N; Matsumoto S
    No Shinkei Geka; 1988 Jun; 16(7):819-26. PubMed ID: 3221965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.